Thursday, May 8, 2025

Latest

PharmaDrug: A Path To Safe Supply

FULL DISCLOSURE: This content is sponsored by PharmaDrug Inc.

In this interview, David Kideckel, CEO of PharmaDrug (CSE: PHRX), discusses the company’s groundbreaking biosynthetic manufacturing method for pharmaceutical-grade cocaine. The focus is on addressing the fentanyl crisis and providing safe supply programs for overcoming illicit drug addiction. PharmaDrug aims to combat substance abuse through biosynthesis, ensuring consistent, pure, and cost-effective production of cocaine.

READ: Biosynthetic Cocaine? PharmaDrug Files Patent For Novel Manufacturing Method

David highlights the company’s history, his background, and potential markets, emphasizing harm reduction. The interview explores revenue opportunities, scalability, and ongoing regulatory efforts.


FULL DISCLOSURE: PharmaDrug is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of PharmaDrug. The author has been compensated to cover PharmaDrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Related News

PharmaDrug Anticipates Biosynthetic Cocaine Commercial-Scale Production In As Little As 12 Months

PharmaDrug Inc (CSE: PHRX) has established a strategic plan to push forward with its intent...
Monday, May 13, 2024, 08:55:00 AM

Pharmadrug Completes Super Smart Acquisition, Issues 64.4 Million Free Trading Shares

Pharmadrug Inc (CSE: BUZZ) announced this morning that it has completed its acquisition of Interrobang...

Monday, June 15, 2020, 02:44:06 PM

Red Light Holland, Pharmadrug Enter Share Exchange Agreement

It appears that Red Light Holland (CSE: TRIP) and Pharmadrug Inc (CSE: BUZZ) have entered...

Wednesday, July 15, 2020, 09:45:07 AM

PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial

Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics,...
Monday, August 19, 2024, 09:08:46 AM

PharmaDrug JV Submits Application For Phase 1 Clinical Trials In Australia

PharmaDrug Inc (CSE: DRUG) has seen one of its joint ventures advance to the clinical...
Wednesday, May 15, 2024, 09:17:48 AM